This presentation is about how to design a public health campaign to increase awareness of long-acting injectable PrEP among Black men who have sex with men (BMSM) in Los Angeles County through community-driven recommendations. We conducted focus groups, which highlighted ideas about clear, factual messaging, authentic representation, trusted messengers, and careful visual choices to address stigma and medical mistrust among the BMSM community.
Public health campaigns offer one strategy to increase awareness of HIV prevention options among at-risk populations. However, what is currently lacking in the literature is research on the development of a long-acting injectable PrEP campaign for disproportionately affected populations. Therefore, this study solicited community recommendations from LMSM for a campaign to raise awareness of LAI PrEP among this population in LAC.
This presentation shares key lessons from the T.H3.E. Project on conducting community-driven HIV research with housing-insecure TGI women. Drawing from qualitative implementation data, it highlights strengths and challenges in data collection, including participant compensation, consent processes, community-rooted recruitment, and the impact of local political climates.
This presentation introduces new insights into measuring how overlapping experiences of racial and sexual orientation–based discrimination shape health and medical trust among Black and Latino gay and bisexual men. By comparing multiple methods for measuring intersectional stigma, the study found that a concise, intersectional scale performs nearly as well as longer, identity-specific measures—offering a reliable and efficient tool for research and community health efforts. The findings offer flexible strategies for capturing complex experiences of stigma and advancing more inclusive public health research.
Syndemic framework has been widely used to note the co-occurrence of intimate partner violence (IPV), depression, and engagement in HIV care among sexual minority men (SMM). We find that depressive symptoms fully mediated the association between past-year IPV victimization and future ART nonadherence, after controlling for past ART nonadherence. Our findings highlight a need for a trauma-informed approach for IPV survivors who are young Black SMM living with HIV, with specific emphasis on addressing depression among them to ensure improved treatment adherence.
This presentation will focus on the science of prevention, emphasizing youth risk behavior. Dr. Skeer will present research on adolescent substance use prevention strategies, with a focus on family engagement, communication, and family meals. She will share insights on using substance use as a lens for HIV prevention, highlighting opportunities for integrated approaches.
Peter W. Hunt, M.D will review the evidence supporting a potential role of asymptomatic CMV co-infection as a driver of persistent immune dysfunction and morbidity and mortality in people treated with HIV. He will also describe exciting results from a recent clinical trial of letermovir supporting a causal role of CMV in these processes as well as functional aging outcomes in this setting.
This presentation is on the Howard University’s differentiated service delivery (DSD-Plus) model which is an innovative approach that seeks to contribute to the national 2030 HIV epidemic control in Zambia. The DSD-Plus model is a treatment quality assurance program that ensures adherence, continuity in care(retention), viral load suppression and transition for sustainability. Through such interventions, Zambia is among the six countries to have reached the UNAIDS95-95-95 targets for 2025.
In this presentation, Dr. Barrington will first provide a summary of the context of HIV prevention and care for transgender women in the Dominican Republic. She will then describe her collaborative mixed methods research process to develop and test an intervention to improve HIV care and treatment outcomes and promote overall wellbeing among transwomen with HIV in Santo Domingo.
We model longitudinal trends in viral suppression before and after the transition to telehealth services during COVID-19 pandemic. The expected probability of viral suppression was not negatively impacted by tele-health adoption.